Morgan Stanley’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $688K | Sell |
608,969
-1,744,132
| -74% | -$1.97M | ﹤0.01% | 5302 |
|
2025
Q1 | $3.44M | Buy |
2,353,101
+1,354,505
| +136% | +$1.98M | ﹤0.01% | 4227 |
|
2024
Q4 | $2.13M | Sell |
998,596
-722,934
| -42% | -$1.54M | ﹤0.01% | 4653 |
|
2024
Q3 | $4.82M | Sell |
1,721,530
-435,432
| -20% | -$1.22M | ﹤0.01% | 3987 |
|
2024
Q2 | $5.03M | Sell |
2,156,962
-75,002
| -3% | -$175K | ﹤0.01% | 3869 |
|
2024
Q1 | $9.98M | Sell |
2,231,964
-1,103,688
| -33% | -$4.93M | ﹤0.01% | 3353 |
|
2023
Q4 | $10.7M | Buy |
3,335,652
+1,953,934
| +141% | +$6.27M | ﹤0.01% | 3857 |
|
2023
Q3 | $4.38M | Buy |
1,381,718
+50,281
| +4% | +$159K | ﹤0.01% | 3854 |
|
2023
Q2 | $6.62M | Buy |
1,331,437
+349,962
| +36% | +$1.74M | ﹤0.01% | 3548 |
|
2023
Q1 | $4.85M | Buy |
981,475
+130,996
| +15% | +$647K | ﹤0.01% | 3815 |
|
2022
Q4 | $5.35M | Buy |
850,479
+234,460
| +38% | +$1.47M | ﹤0.01% | 3697 |
|
2022
Q3 | $6.65M | Sell |
616,019
-521,246
| -46% | -$5.63M | ﹤0.01% | 3404 |
|
2022
Q2 | $13M | Sell |
1,137,265
-551,176
| -33% | -$6.28M | ﹤0.01% | 2787 |
|
2022
Q1 | $15.4M | Buy |
1,688,441
+422,386
| +33% | +$3.85M | ﹤0.01% | 2406 |
|
2021
Q4 | $18.9M | Buy |
1,266,055
+203,029
| +19% | +$3.03M | ﹤0.01% | 2220 |
|
2021
Q3 | $27.3M | Sell |
1,063,026
-66,452
| -6% | -$1.71M | ﹤0.01% | 1774 |
|
2021
Q2 | $29.5M | Buy |
1,129,478
+1,035,898
| +1,107% | +$27M | ﹤0.01% | 1756 |
|
2021
Q1 | $3.3M | Sell |
93,580
-249,202
| -73% | -$8.79M | ﹤0.01% | 3838 |
|
2020
Q4 | $8.65M | Buy |
342,782
+142,367
| +71% | +$3.59M | ﹤0.01% | 2667 |
|
2020
Q3 | $7.56M | Buy |
200,415
+153,345
| +326% | +$5.78M | ﹤0.01% | 2296 |
|
2020
Q2 | $2.02M | Sell |
47,070
-259
| -0.5% | -$11.1K | ﹤0.01% | 3590 |
|
2020
Q1 | $920K | Sell |
47,329
-32,837
| -41% | -$638K | ﹤0.01% | 4020 |
|
2019
Q4 | $2.08M | Buy |
80,166
+48,492
| +153% | +$1.26M | ﹤0.01% | 4005 |
|
2019
Q3 | $864K | Buy |
31,674
+21,967
| +226% | +$599K | ﹤0.01% | 4382 |
|
2019
Q2 | $260K | Buy |
9,707
+691
| +8% | +$18.5K | ﹤0.01% | 4913 |
|
2019
Q1 | $260K | Sell |
9,016
-27,715
| -75% | -$799K | ﹤0.01% | 4919 |
|
2018
Q4 | $990K | Buy |
+36,731
| New | +$990K | ﹤0.01% | 4283 |
|